MDRX vs. SPY
Compare and contrast key facts about Allscripts Healthcare Solutions, Inc. (MDRX) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDRX or SPY.
Correlation
The correlation between MDRX and SPY is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MDRX vs. SPY - Performance Comparison
Key characteristics
MDRX:
-0.62
SPY:
1.81
MDRX:
-0.60
SPY:
2.43
MDRX:
0.91
SPY:
1.33
MDRX:
-0.42
SPY:
2.74
MDRX:
-2.69
SPY:
11.36
MDRX:
13.98%
SPY:
2.03%
MDRX:
60.62%
SPY:
12.74%
MDRX:
-97.79%
SPY:
-55.19%
MDRX:
-88.40%
SPY:
-0.73%
Returns By Period
In the year-to-date period, MDRX achieves a -45.64% return, which is significantly lower than SPY's 3.28% return. Over the past 10 years, MDRX has underperformed SPY with an annualized return of -7.71%, while SPY has yielded a comparatively higher 13.17% annualized return.
MDRX
-45.64%
-44.27%
-44.21%
-38.59%
-10.21%
-7.71%
SPY
3.28%
4.28%
12.39%
22.37%
14.20%
13.17%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDRX vs. SPY — Risk-Adjusted Performance Rank
MDRX
SPY
MDRX vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Allscripts Healthcare Solutions, Inc. (MDRX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDRX vs. SPY - Dividend Comparison
MDRX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.17%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDRX Allscripts Healthcare Solutions, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.17% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
MDRX vs. SPY - Drawdown Comparison
The maximum MDRX drawdown since its inception was -97.79%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for MDRX and SPY. For additional features, visit the drawdowns tool.
Volatility
MDRX vs. SPY - Volatility Comparison
Allscripts Healthcare Solutions, Inc. (MDRX) has a higher volatility of 42.53% compared to SPDR S&P 500 ETF (SPY) at 3.41%. This indicates that MDRX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.